These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 27264179)

  • 1. A Computational Drug Repositioning Approach for Targeting Oncogenic Transcription Factors.
    Gayvert KM; Dardenne E; Cheung C; Boland MR; Lorberbaum T; Wanjala J; Chen Y; Rubin MA; Tatonetti NP; Rickman DS; Elemento O
    Cell Rep; 2016 Jun; 15(11):2348-56. PubMed ID: 27264179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-Induced Expression-Based Computational Repurposing of Small Molecules Affecting Transcription Factor Activity.
    Gayvert K; Elemento O
    Methods Mol Biol; 2019; 1903():179-184. PubMed ID: 30547442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-Based Methods for the Identification of Myc-Inhibitory Small Molecules.
    Burkhart CA; Haber M; Norris MD; Gudkov AV; Nikiforov MA
    Methods Mol Biol; 2021; 2318():337-346. PubMed ID: 34019301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to everolimus driven by epigenetic regulation of MYC in ER+ breast cancers.
    Bihani T; Ezell SA; Ladd B; Grosskurth SE; Mazzola AM; Pietras M; Reimer C; Zinda M; Fawell S; D'Cruz CM
    Oncotarget; 2015 Feb; 6(4):2407-20. PubMed ID: 25537515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational drugs repositioning identifies inhibitors of oncogenic PI3K/AKT/P70S6K-dependent pathways among FDA-approved compounds.
    Carrella D; Manni I; Tumaini B; Dattilo R; Papaccio F; Mutarelli M; Sirci F; Amoreo CA; Mottolese M; Iezzi M; Ciolli L; Aria V; Bosotti R; Isacchi A; Loreni F; Bardelli A; Avvedimento VE; di Bernardo D; Cardone L
    Oncotarget; 2016 Sep; 7(37):58743-58758. PubMed ID: 27542212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The BET bromodomain inhibitor CPI203 improves lenalidomide and dexamethasone activity in
    Díaz T; Rodríguez V; Lozano E; Mena MP; Calderón M; Rosiñol L; Martínez A; Tovar N; Pérez-Galán P; Bladé J; Roué G; de Larrea CF
    Haematologica; 2017 Oct; 102(10):1776-1784. PubMed ID: 28751557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription factor enrichment analysis (TFEA) quantifies the activity of multiple transcription factors from a single experiment.
    Rubin JD; Stanley JT; Sigauke RF; Levandowski CB; Maas ZL; Westfall J; Taatjes DJ; Dowell RD
    Commun Biol; 2021 Jun; 4(1):661. PubMed ID: 34079046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of BRD4 suppresses tumor growth in prostate cancer via the enhancement of FOXO1 expression.
    Tan Y; Wang L; Du Y; Liu X; Chen Z; Weng X; Guo J; Chen H; Wang M; Wang X
    Int J Oncol; 2018 Dec; 53(6):2503-2517. PubMed ID: 30272279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compensatory RNA polymerase 2 loading determines the efficacy and transcriptional selectivity of JQ1 in Myc-driven tumors.
    Donato E; Croci O; Sabò A; Muller H; Morelli MJ; Pelizzola M; Campaner S
    Leukemia; 2017 Feb; 31(2):479-490. PubMed ID: 27443262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-based methods for the identification of MYC-inhibitory small molecules.
    Burkhart CA; Haber M; Norris MD; Gudkov AV; Nikiforov MA
    Methods Mol Biol; 2013; 1012():255-64. PubMed ID: 24006071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revealing transcription factor and histone modification co-localization and dynamics across cell lines by integrating ChIP-seq and RNA-seq data.
    Zhang L; Xue G; Liu J; Li Q; Wang Y
    BMC Genomics; 2018 Dec; 19(Suppl 10):914. PubMed ID: 30598100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting bromodomain-containing protein 4 (BRD4) inhibits MYC expression in colorectal cancer cells.
    Otto C; Schmidt S; Kastner C; Denk S; Kettler J; Müller N; Germer CT; Wolf E; Gallant P; Wiegering A
    Neoplasia; 2019 Nov; 21(11):1110-1120. PubMed ID: 31734632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BET Bromodomain Inhibition Suppresses the Function of Hematopoietic Transcription Factors in Acute Myeloid Leukemia.
    Roe JS; Mercan F; Rivera K; Pappin DJ; Vakoc CR
    Mol Cell; 2015 Jun; 58(6):1028-39. PubMed ID: 25982114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CBFβ-SMMHC Inhibition Triggers Apoptosis by Disrupting MYC Chromatin Dynamics in Acute Myeloid Leukemia.
    Pulikkan JA; Hegde M; Ahmad HM; Belaghzal H; Illendula A; Yu J; O'Hagan K; Ou J; Muller-Tidow C; Wolfe SA; Zhu LJ; Dekker J; Bushweller JH; Castilla LH
    Cell; 2018 Jun; 174(1):172-186.e21. PubMed ID: 29958106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TICA: Transcriptional Interaction and Coregulation Analyzer.
    Perna S; Pinoli P; Ceri S; Wong L
    Genomics Proteomics Bioinformatics; 2018 Oct; 16(5):342-353. PubMed ID: 30578913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JQ1 and PI3K inhibition synergistically reduce salivary adenoid cystic carcinoma malignancy by targeting the c-Myc and EGFR signaling pathways.
    Liu X; Wu H; Huang P; Zhang F
    J Oral Pathol Med; 2019 Jan; 48(1):43-51. PubMed ID: 30269363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JQ1, an inhibitor of the epigenetic reader BRD4, suppresses the bidirectional MYC-AP4 axis via multiple mechanisms.
    Choi SK; Hong SH; Kim HS; Shin CY; Nam SW; Choi WS; Han JW; You JS
    Oncol Rep; 2016 Feb; 35(2):1186-94. PubMed ID: 26573731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BET bromodomain inhibition rescues erythropoietin differentiation of human erythroleukemia cell line UT7.
    Goupille O; Penglong T; Lefèvre C; Granger M; Kadri Z; Fucharoen S; Maouche-Chrétien L; Leboulch P; Chrétien S
    Biochem Biophys Res Commun; 2012 Dec; 429(1-2):1-5. PubMed ID: 23137537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription Factor Activities Enhance Markers of Drug Sensitivity in Cancer.
    Garcia-Alonso L; Iorio F; Matchan A; Fonseca N; Jaaks P; Peat G; Pignatelli M; Falcone F; Benes CH; Dunham I; Bignell G; McDade SS; Garnett MJ; Saez-Rodriguez J
    Cancer Res; 2018 Feb; 78(3):769-780. PubMed ID: 29229604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of small molecule inhibitor JQ1.
    Decker TM; Kluge M; Krebs S; Shah N; Blum H; Friedel CC; Eick D
    Sci Rep; 2017 May; 7(1):1684. PubMed ID: 28490802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.